Filing Details

Accession Number:
0001708138-20-000108
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-18 16:02:15
Reporting Period:
2020-11-16
Accepted Time:
2020-11-18 16:02:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796226 J Andrew Murphy 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-16 13,736 $30.63 60,872 No 4 M Direct
Common Stock Disposition 2020-11-16 7,108 $561.39 53,764 No 4 F Direct
Common Stock Disposition 2020-11-17 743 $536.68 53,021 No 4 S Direct
Common Stock Disposition 2020-11-17 229 $537.38 52,792 No 4 S Direct
Common Stock Disposition 2020-11-17 591 $538.37 52,201 No 4 S Direct
Common Stock Disposition 2020-11-17 42 $539.87 52,159 No 4 S Direct
Common Stock Disposition 2020-11-17 1,442 $540.49 50,717 No 4 S Direct
Common Stock Disposition 2020-11-17 812 $541.42 49,905 No 4 S Direct
Common Stock Disposition 2020-11-17 294 $542.37 49,611 No 4 S Direct
Common Stock Disposition 2020-11-17 467 $543.65 49,144 No 4 S Direct
Common Stock Disposition 2020-11-17 68 $544.01 49,076 No 4 S Direct
Common Stock Disposition 2020-11-17 171 $545.47 48,905 No 4 S Direct
Common Stock Disposition 2020-11-17 524 $546.61 48,381 No 4 S Direct
Common Stock Disposition 2020-11-17 148 $547.12 48,233 No 4 S Direct
Common Stock Disposition 2020-11-17 216 $548.77 48,017 No 4 S Direct
Common Stock Disposition 2020-11-17 283 $549.67 47,734 No 4 S Direct
Common Stock Disposition 2020-11-17 206 $550.71 47,528 No 4 S Direct
Common Stock Disposition 2020-11-17 141 $551.48 47,387 No 4 S Direct
Common Stock Disposition 2020-11-17 73 $552.88 47,314 No 4 S Direct
Common Stock Disposition 2020-11-17 64 $553.21 47,250 No 4 S Direct
Common Stock Disposition 2020-11-17 114 $556.45 47,136 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-11-16 13,736 $0.00 13,736 $30.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,242 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 743 shares of Company stock on November 17, 2020 at prices ranging from $536.41 to $536.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 229 shares of Company stock on November 17, 2020 at prices ranging from $537.15 to $537.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 591 shares of Company stock on November 17, 2020 at prices ranging from $538.03 to $538.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 42 shares of Company stock on November 17, 2020 at prices ranging from $539.50 to $539.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 1,442 shares of Company stock on November 17, 2020 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  7. Represents volume-weighted average price of sales of 812 shares of Company stock on November 17, 2020 at prices ranging from $541.01 to $541.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  8. Represents volume-weighted average price of sales of 294 shares of Company stock on November 17, 2020 at prices ranging from $542.15 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  9. Represents volume-weighted average price of sales of 467 shares of Company stock on November 17, 2020 at prices ranging from $543.07 to $543.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  10. Represents volume-weighted average price of sales of 171 shares of Company stock on November 17, 2020 at prices ranging from $545.37 to $545.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  11. Represents volume-weighted average price of sales of 524 shares of Company stock on November 17, 2020 at prices ranging from $546.08 to $546.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  12. Represents volume-weighted average price of sales of 148 shares of Company stock on November 17, 2020 at prices ranging from $547.12 to $547.20. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  13. Represents volume-weighted average price of sales of 216 shares of Company stock on November 17, 2020 at prices ranging from $548.47 to $548.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  14. Represents volume-weighted average price of sales of 283 shares of Company stock on November 17, 2020 at prices ranging from $549.03 to $549.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  15. Represents volume-weighted average price of sales of 206 shares of Company stock on November 17, 2020 at prices ranging from $550.52 to $550.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  16. Represents volume-weighted average price of sales of 141 shares of Company stock on November 17, 2020 at prices ranging from $551.31 to $551.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  17. Represents volume-weighted average price of sales of 114 shares of Company stock on November 17, 2020 at prices ranging from $556.38 to $556.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 17, 2020 at each separate price.
  18. The stock option award vests in four equal annual installments, commencing one year after the date of grant.